The Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria 3052, Australia.
Nat Commun. 2017 Mar 6;8:14581. doi: 10.1038/ncomms14581.
The Eμ-Myc mouse is an extensively used model of MYC driven malignancy; however to date there has only been partial characterization of MYC co-operative mutations leading to spontaneous lymphomagenesis. Here we sequence spontaneously arising Eμ-Myc lymphomas to define transgene architecture, somatic mutations, and structural alterations. We identify frequent disruptive mutations in the PRC1-like component and BCL6-corepressor gene Bcor. Moreover, we find unexpected concomitant multigenic lesions involving Cdkn2a loss and other cancer genes including Nras, Kras and Bcor. These findings challenge the assumed two-hit model of Eμ-Myc lymphoma and demonstrate a functional in vivo role for Bcor in suppressing tumorigenesis.
Eμ-Myc 小鼠是一种广泛应用于 MYC 驱动恶性肿瘤的模型;然而,迄今为止,只有对导致自发性淋巴瘤发生的 MYC 合作突变的部分特征进行了描述。在这里,我们对自发出现的 Eμ-Myc 淋巴瘤进行测序,以确定转基因结构、体细胞突变和结构改变。我们鉴定了 PRC1 样成分和 BCL6 核心抑制基因 Bcor 中的频繁破坏性突变。此外,我们还发现了意想不到的伴随多基因病变,包括 Cdkn2a 缺失和其他癌症基因,如 Nras、Kras 和 Bcor。这些发现挑战了 Eμ-Myc 淋巴瘤的假定双打击模型,并证明了 Bcor 在抑制肿瘤发生中的体内功能作用。